For instance, increased expression of NF-κB has been observed in the mucosal cells of patients with inflammatory bowel disease (IBD), while pharmacological interventions targeting NF-κB can ameliorate intestinal inflammation in mouse models of colitis (40). This evidence concerns the gene NFKB1 and inflammatory bowel disease.